The approval is based on results of the AcT trial, where tenecteplase was comparable to alteplase for safety and efficacy.

The FDA says user challenges and need for additional procedures drove recommendations to stop using the system immediately.

Though arterial thrombotic risk was higher with hormonal contraception use, the absolute excess risks were low.

Intensifying oral diuretic therapy was linked to worse prognosis, but not everybody is sold on its use an endpoint.

A review highlights how, amid shifts in care delivery, US veterans can still find high quality at their VA medical center.

Clinicians having unconscious pro-white bias led to low-value PAD care and greater risks for amputation in Black patients.

Hopes for a separate board responsible for certifying cardiologists were dashed Friday when leaders laying the groundwork for ...

For all news and slides from the THT 2025 meeting, check out our conference page and or tune in to the Heart Sounds podcast ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...